Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9286 |
High Similarity |
NPD3027 |
Phase 3 |
0.8976 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8906 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8779 |
High Similarity |
NPD1613 |
Approved |
0.8779 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD3018 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8361 |
Intermediate Similarity |
NPD228 |
Approved |
0.8346 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8295 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8226 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8195 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8134 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8092 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8041 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7955 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7955 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD2801 |
Approved |
0.791 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7903 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7903 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7872 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7829 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7826 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.781 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7733 |
Intermediate Similarity |
NPD37 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7697 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7671 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7623 |
Intermediate Similarity |
NPD846 |
Approved |
0.7623 |
Intermediate Similarity |
NPD940 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7591 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7582 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7582 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD4966 |
Approved |
0.758 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7557 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7541 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7537 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7537 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7534 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7431 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7403 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7402 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7388 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7324 |
Intermediate Similarity |
NPD943 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD1357 |
Approved |
0.731 |
Intermediate Similarity |
NPD6099 |
Approved |
0.731 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7296 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7292 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.726 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7246 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7219 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7213 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7213 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7211 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5089 |
Approved |
0.72 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD290 |
Approved |
0.7183 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7183 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7183 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7177 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7169 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7169 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7131 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7131 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7131 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7114 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7114 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD5451 |
Approved |
0.707 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7034 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7034 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7007 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7 |
Intermediate Similarity |
NPD1283 |
Approved |
0.6988 |
Remote Similarity |
NPD7240 |
Approved |
0.6988 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6987 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD7411 |
Suspended |
0.6986 |
Remote Similarity |
NPD6651 |
Approved |
0.6981 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6978 |
Remote Similarity |
NPD2233 |
Approved |
0.6978 |
Remote Similarity |
NPD2232 |
Approved |
0.6978
|
Remote Similarity |
NPD2230 |
Approved |